What do analysts expect the price target to be for RH (RH)?
28 analysts have analysed RH and the average price target is 211.4 USD. This implies a price increase of 55.15% is expected in the next year compared to the current price of 136.25.
NYSE:RH • US74967X1037
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for RH (RH).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-17 | UBS | Maintains | Neutral -> Neutral |
| 2026-03-13 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2026-01-20 | TD Cowen | Maintains | Buy -> Buy |
| 2026-01-15 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-12-19 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-12-15 | Barclays | Maintains | Overweight -> Overweight |
| 2025-12-15 | Goldman Sachs | Maintains | Sell -> Sell |
| 2025-12-12 | TD Cowen | Maintains | Buy -> Buy |
| 2025-12-12 | Stifel | Downgrade | Buy -> Hold |
| 2025-12-12 | Telsey Advisory Group | Maintains | Market Perform -> Market Perform |
| 2025-12-12 | Baird | Maintains | Neutral -> Neutral |
| 2025-12-12 | B of A Securities | Maintains | Underperform -> Underperform |
| 2025-10-02 | William Blair | Downgrade | Outperform -> Market Perform |
| 2025-09-12 | TD Cowen | Maintains | Buy -> Buy |
| 2025-09-12 | Guggenheim | Reiterate | Buy -> Buy |
| 2025-09-12 | Stifel | Maintains | Buy -> Buy |
| 2025-09-12 | Barclays | Maintains | Overweight -> Overweight |
| 2025-09-12 | Telsey Advisory Group | Downgrade | Outperform -> Market Perform |
| 2025-09-08 | Telsey Advisory Group | Maintains | Outperform -> Outperform |
| 2025-09-08 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-09-03 | Citigroup | Maintains | Neutral -> Neutral |
| 2025-07-09 | Zelman & Assoc | Maintains | Outperform -> Outperform |
| 2025-07-02 | Guggenheim | Reiterate | Buy -> Buy |
| 2025-06-24 | Goldman Sachs | Downgrade | Neutral -> Sell |
| 2025-06-16 | Baird | Maintains | Neutral -> Neutral |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 3.591B -4.48% | 3.029B -15.63% | 3.181B 5.01% | 3.576B 12.43% | 3.895B 8.92% | 4.203B 7.91% | 4.638B 10.35% | 4.888B 5.39% | 5.281B 8.04% | 5.706B 8.05% | 6.166B 8.06% | 6.662B 8.04% | |
| EBITDA YoY % growth | 825.8M -19.28% | 493.56M -40.23% | 443.403M -10.16% | 599.12M 35.12% | 677.44M 13.07% | 770.89M 13.79% | 893.94M 15.96% | 1.222B 36.70% | 1.319B 7.94% | N/A | N/A | N/A | |
| EBIT YoY % growth | 717.2M -22.64% | 374.571M -47.77% | 313.212M -16.38% | 422.92M 35.03% | 491.58M 16.23% | 567.79M 15.50% | 703.45M 23.89% | 904.21M 28.54% | 1.03B 13.91% | 1.118B 8.54% | 1.215B 8.68% | 1.319B 8.56% | |
| Operating Margin | 19.97% | 12.37% | 9.85% | 11.83% | 12.62% | 13.51% | 15.17% | 18.50% | 19.50% | 19.59% | 19.70% | 19.80% | |
| EPS YoY % growth | 24.41 -6.33% | 6.44 -73.62% | 5.35 -16.93% | 7.30 36.40% | 10.75 47.25% | 14.69 36.75% | 21.05 43.25% | 34.95 66.02% | 41.52 18.80% | 48.19 16.08% | 56.10 16.41% | 65.55 16.83% |
All data in USD
| Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | Q4 / 28 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 2.39 50.99% | 0.52 297.85% | 3.63 23.79% | 3.15 83.94% | 3.28 37.69% | 1.91 268.42% | 4.97 37.16% | 4.89 55.55% | 3.51 6.93% |
| Revenue Q2Q % growth | 901.75M 11.00% | 909.85M 11.78% | 1.008B 12.11% | 993.03M 12.36% | 979.79M 8.65% | 977.47M 7.43% | 1.08B 7.14% | 1.062B 6.95% | 1.05B 7.17% |
| EBITDA Q2Q % growth | 167.64M -16.40% | 111.77M 22.63% | 201.69M 1.48% | 184.33M -12.56% | 190.31M 13.52% | 131.17M 17.36% | 246.17M 22.05% | 210.27M 14.07% | 198.64M 4.38% |
| EBIT Q2Q % growth | 119.94M 70.54% | 66.721M 19.33% | 153.52M 19.12% | 134.3M 30.95% | 137.98M 15.04% | 80.649M 20.87% | 186.43M 21.44% | 158.67M 18.15% | 146.93M 6.49% |
All data in USD
28 analysts have analysed RH and the average price target is 211.4 USD. This implies a price increase of 55.15% is expected in the next year compared to the current price of 136.25.
RH (RH) will report earnings on 2026-06-10.
The consensus EPS estimate for the next earnings of RH (RH) is 2.39 USD and the consensus revenue estimate is 901.75M USD.
The number of analysts covering RH (RH) is 28.